UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

The lancet oncology, 2017-11, Vol.18 (11), p.1493-1501

2017

Volltextzugriff (PDF)

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Journal of clinical oncology, 2008-02, Vol.26 (4), p.626-632

2008

Volltextzugriff (PDF)

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4541-4547

2011

Volltextzugriff (PDF)

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

Molecular cancer therapeutics, 2016-05, Vol.15 (5), p.1018-1028

2016

Volltextzugriff (PDF)

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4188-4196

2009

Volltextzugriff (PDF)

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

Journal of clinical oncology, 2012-01, Vol.30 (1), p.78-84

2012

Volltextzugriff (PDF)

Chordoma: The Nonsarcoma Primary Bone Tumor

The oncologist (Dayton, Ohio), 2007-11, Vol.12 (11), p.1344-1350

2007

Volltextzugriff (PDF)

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

Clinical cancer research, 2010-10, Vol.16 (19), p.4884-4891

2010

Volltextzugriff (PDF)

Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)

Cancer causes & control, 2013-02, Vol.24 (2), p.209-215

2013

Volltextzugriff (PDF)

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3148-3153

2009

Volltextzugriff (PDF)

Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases

Complexity (New York, N.Y.), 2019, Vol.2019 (2019), p.1-6

2019

Volltextzugriff (PDF)

The necessity for rigour in rare disease study design

The lancet oncology, 2019-09, Vol.20 (9), p.1190-1192

Baker, Laurence H

2019

Volltextzugriff (PDF)

Reduced infectivity of waterborne viable but nonculturable Helicobacter pylori strain SS1 in mice

Helicobacter (Cambridge, Mass.), 2017-08, Vol.22 (4), p.n/a

2017

Volltextzugriff (PDF)

Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treament With Gemcitabine Followed by Docetaxel in the Treatment of Sarcoma

Journal of clinical oncology, 2004-05, Vol.22 (9), p.1706-1712

2004

Volltextzugriff (PDF)

Differential Outcomes and Biologic Markers of Radiation-Associated vs. Sporadic Osteosarcoma: A Single-Institution Experience

Frontiers in oncology, 2020-01, Vol.9, p.1523-1523

2020

Volltextzugriff (PDF)

Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5583-5588

2008

Volltextzugriff (PDF)

Integrative clinical genomics of metastatic cancer

Nature (London), 2017-08, Vol.548 (7667), p.297-303

2017

Volltextzugriff (PDF)

Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru

Infection and drug resistance, 2017-01, Vol.10, p.85-90

2017

Volltextzugriff (PDF)

Cancer Survivorship-A Call to Action

JAMA oncology, 2020-05, Vol.6 (5), p.632

Baker, Laurence H

2020

Volltextzugriff (PDF)

Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma

Molecular cancer therapeutics, 2013-09, Vol.12 (9), p.1701-1714

2013

Volltextzugriff (PDF)

Histologic Alterations from Neoadjuvant Chemotherapy in High‐Grade Extremity Soft Tissue Sarcoma: Clinicopathological Correlation

The oncologist (Dayton, Ohio), 2008-04, Vol.13 (4), p.451-458

2008

Volltextzugriff (PDF)

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

JAMA : the journal of the American Medical Association, 2011-10, Vol.306 (14), p.1549

2011

Volltextzugriff (PDF)

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy

Breast cancer research and treatment, 2005-08, Vol.92 (3), p.231-238

2005

Volltextzugriff (PDF)

Adjuvant Therapy for High-Grade, Uterus-Limited Leiomyosarcoma: Results of a Phase 2 Trial (SARC 005)

Cancer, 2013-04, Vol.119 (8), p.1555-1561

2013

Volltextzugriff (PDF)

1 – 25 von 420

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(360)
Mit Volltextzugriff
(328)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(419)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(243)
Humans
(240)
Life Sciences & Biomedicine
(230)
Male
(146)
Female
(141)
Oncology
(135)
Middle Aged
(130)
Adult
(128)
Biological And Medical Sciences
(115)
Medical Sciences
(112)
Aged
(104)
Pharmacology. Drug Treatments
(57)
Chemotherapy
(52)
Antineoplastic Agents
(48)
Sarcoma - Drug Therapy
(39)
Adolescent
(37)
Treatment Outcome
(36)
Antineoplastic Agents - Therapeutic Use
(34)
Tumors
(34)
Coping With Illness
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

Chordoma: The Nonsarcoma Primary Bone Tumor

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model

Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases

The necessity for rigour in rare disease study design

Reduced infectivity of waterborne viable but nonculturable Helicobacter pylori strain SS1 in mice

Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treament With Gemcitabine Followed by Docetaxel in the Treatment of Sarcoma

Differential Outcomes and Biologic Markers of Radiation-Associated vs. Sporadic Osteosarcoma: A Single-Institution Experience

Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma

Integrative clinical genomics of metastatic cancer

Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru

Cancer Survivorship-A Call to Action

Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma

Histologic Alterations from Neoadjuvant Chemotherapy in High‐Grade Extremity Soft Tissue Sarcoma: Clinicopathological Correlation

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy

Adjuvant Therapy for High-Grade, Uterus-Limited Leiomyosarcoma: Results of a Phase 2 Trial (SARC 005)

Suchergebnisse filtern